- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02922309
Comparing Telepractice and Conventional Face-to-face Voice Therapy
Voice Therapy for Benign Voice Disorders in the Elderly: A Randomized Controlled Trial Comparing Telepractice and Conventional Face-to-face Therapy
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Randomization: per mutated block, 40 patients on each arms (experimental and control)
Allocation: sealed envelope indicating either of the 2 groups
Intervention: weekly vocal training, each course last for 30-40 minutes,lasting for 2 months
Outcome measurement: before treatment, 1 month, 3 months, and 6 months after treatment
Primary outcome: 10-item voice handicap index
Secondary outcome: acoustics and aerodynamic parameter
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion criteria:
- patient equal or older than 55 years old
- Voice Handicap Index-10 (VHI-10) score >10 point
- accessibility to a network connection
Exclusion criteria
- neurologic disorders
- active pulomanory disease
- mental disorder
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: experimental
Vocal Training via Telepractice
|
Vocal Training Via Telepractice, delivered by integrated communication service
|
Comparador activo: control
Vocal Training via face-to-face practice
|
Vocal Training Via face-to face practice at medical facilities
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change from Baseline of 10-item voice handicap index at 2 months
Periodo de tiempo: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
min: 0(best); Max: 40(worst);
|
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Perceptual Analysis using grade, roughness, breathiness, asthenia, and strain
Periodo de tiempo: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
from 0(best) to 3(worst)
|
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
Jitter
Periodo de tiempo: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
percentage of jitter based on continuous vowel
|
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
Shimmer
Periodo de tiempo: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
decibel (dB) of shimmer based on continuous vowel
|
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
Noise to harmonic ratio
Periodo de tiempo: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
Noise to harmonic ratio based on continuous vowel
|
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
smoothed Cepstrum peak prominence
Periodo de tiempo: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
based on reading a Mandarin passage
|
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
Maximal phonation time
Periodo de tiempo: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
seconds
|
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
VLS
Periodo de tiempo: before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
Videolaryngostroboscopy (mucosal wave: normal, mildly decreased, severely decreased, absent)
|
before treatment (after signing informed consent, prior to randomization) and within 2 weeks after the completion of voice therapy
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Chi-Te Wang, MD, PhD, Department of Otolaryngology, Far Eastern Memorial Hospital
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Desordenes mentales
- Enfermedades del Sistema Nervioso
- Enfermedades de las vías respiratorias
- Manifestaciones neurológicas
- Manifestaciones neuroconductuales
- Enfermedades Otorrinolaringológicas
- Trastornos del neurodesarrollo
- Enfermedades de la laringe
- Trastornos de la voz
- Afonía
- Desordenes comunicacionales
Otros números de identificación del estudio
- FEMH-IRB-104193-E
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .